TY - JOUR
T1 - Pharmacogenetics
T2 - ethnicity, treatment and health in Latin American populations
AU - Sosa-Macías, Martha
AU - Fricke-Galindo, Ingrid
AU - Fariñas, Humberto
AU - Monterde, Lucero
AU - Ruiz-Cruz, Eugenia Dolores
AU - Molina-Guarneros, Juan
AU - Tarazona-Santos, Eduardo
AU - Rodrigues-Soares, Fernanda
AU - Galaviz-Hernández, Carlos
AU - Peñas-Lledó, Eva
AU - Moya, Graciela
AU - Lara-Riegos, Julio
AU - Terán, Enrique
AU - Hernández, Isabel
AU - Ramírez-Roa, Ronald
AU - Altamirano-Tinoco, Catalina
AU - López-López, Marisol
AU - García-Ortiz, José Elías
AU - Llerena, Adrián
N1 - Publisher Copyright:
© 2023 Future Medicine Ltd.
PY - 2023/6/1
Y1 - 2023/6/1
N2 - The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.
AB - The Ibero-American Network of Pharmacogenetics and Pharmacogenomics (RIBEF) studies Latin American populations to benefit from the implementation of personalized medicine. Since 2006, it has studied ethnicity to apply pharmacogenetics knowledge in autochthonous populations of Latin America, considering ancestral medicine. The meeting 'Pharmacogenetics: ethnicity, Treatment and Health in Latin American Populations' was held in Mexico City, Mexico, and presented the relevance of RIBEF collaboration with Latin American researchers and the governments of Mexico, Spain and the Autonomous Community of Extremadura. The results of 17 years of uninterrupted work by RIBEF, the Declaration of Mérida/T'Hó and the call for the Dr José María Cantú Award for studies focused on the pharmacogenetics of native populations in Latin America were presented.
KW - Latin American
KW - Native Americans
KW - biomarkers
KW - ethnicity
KW - pharmacogenetics
UR - http://www.scopus.com/inward/record.url?scp=85168222657&partnerID=8YFLogxK
U2 - 10.2217/pgs-2023-0098
DO - 10.2217/pgs-2023-0098
M3 - Artículo
C2 - 37529900
AN - SCOPUS:85168222657
SN - 1462-2416
VL - 24
SP - 489
EP - 492
JO - Pharmacogenomics
JF - Pharmacogenomics
IS - 9
ER -